Molecular mechanisms and timing of cortical immune activation in schizophrenia

American Journal of Psychiatry

Volumn 172, Issue 11, 2015, Pages 1112-1121

  Volk, David W ^a   Chitrapu, Anjani ^a   Edelson, Jessica R ^a   Roman, Kaitlyn M ^a   Moroco, Annie E ^a   Lewis, David A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON INDUCED TRANSMEMBRANE PROTEIN; INTERLEUKIN 6; MEMBRANE PROTEIN; MESSENGER RNA; POLYINOSINIC POLYCYTIDYLIC ACID; SCHNURRI 2 PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; DIFFERENTIATION ANTIGEN; DNA BINDING PROTEIN; FRAGILIS PROTEIN, MOUSE; FRAGILIS3 PROTEIN, MOUSE; HIVEP2 PROTEIN, HUMAN; IFITM2 PROTEIN, HUMAN; IFITM3 PROTEIN, HUMAN; INTERFERON INDUCING AGENT; LEU-13 ANTIGEN; RNA BINDING PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE ACTIVATION; IMMUNOREGULATION; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PREFRONTAL CORTEX; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SCHIZOPHRENIA; ANIMAL; BRAIN CORTEX; CASE CONTROL STUDY; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PREGNANCY; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; ANIMALS; ANTIGENS, DIFFERENTIATION; CASE-CONTROL STUDIES; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERFERON INDUCERS; INTERFERON-BETA; INTERLEUKIN-6; MALE; MEMBRANE PROTEINS; MICE; MIDDLE AGED; NF-KAPPA B; POLY I-C; PREFRONTAL CORTEX; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA-BINDING PROTEINS; SCHIZOPHRENIA; TRANSCRIPTION FACTORS;

EID: 84946119836     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2015.15010019     Document Type: Article

References (56)

1. Purcell SM, Wray NR, Stone JL, et al: Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009;460:748-752
2. Shi J, Levinson DF, Duan J, et al: Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 2009;460:753-757
3. Stefansson H, Ophoff RA, Steinberg S, et al: Common variants conferring risk of schizophrenia. Nature 2009;460:744-747
4. Jia P, Wang L, Meltzer HY, et al: Commonvariants conferring risk of schizophrenia: a pathway analysis of GWAS data. Schizophr Res 2010;122:38-42
5. Ripke S, Sanders AR, Kendler KS, et al: Genome-wide association study identifies five new schizophrenia loci. Nat Genet 2011;43:969-976
6. Schizophrenia Working Group of the Psychiatric Genomics Consortium: Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014;511:421-427
7. Brown AS, Begg MD, Gravenstein S, et al: Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry 2004;61:774-780
8. Brown AS, Schaefer CA, Quesenberry CP Jr, et al: Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. Am J Psychiatry 2005;162:767-773
9. Brown AS, Hooton J, Schaefer CA, et al: Elevated maternal interleukin-8 levelsand risk of schizophrenia in adult offspring. Am J Psychiatry 2004;161:889-895
10. Canetta S, Sourander A, Surcel HM, et al: Elevated maternal C-reactive protein and increased risk of schizophrenia in a national birth cohort. Am J Psychiatry 2014;171:960-968
11. Brown AS, Derkits EJ: Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry 2010;167:261-280
12. Benros ME, Pedersen MG, Rasmussen H, et al: A nationwide study on the risk of autoimmune diseases in individuals with a personal or a family history of schizophrenia and related psychosis. Am J Psychiatry 2014;171:218-226
13. Benros ME, Eaton WW, Mortensen PB: The epidemiologic evidence linkingautoimmune diseases and psychosis. Biol Psychiatry 2014;75:300-306
14. Potvin S, Stip E, Sepehry AA, et al: Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry 2008;63:801-808
15. Miller BJ, Buckley P, Seabolt W, et al: Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry 2011;70:663-671
16. Di Nicola M, Cattaneo A, Hepgul N, et al: Serum and gene expression profile of cytokines in first-episode psychosis. Brain Behav Immun 2013;31:90-95
17. Fillman SG, Sinclair D, Fung SJ, et al: Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder. Transl Psychiatr 2014;4:e365
18. Fillman SG, Cloonan N, Catts VS, et al: Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia. Mol Psychiatry 2013;18:206-214
19. Arion D, Unger T, Lewis DA, et al: Molecular evidence for increased expression of genes related toimmuneand chaperone function in the prefrontal cortex in schizophrenia. Biol Psychiatry 2007;62:711-721
20. Saetre P, Emilsson L, Axelsson E, et al: Inflammation-related genes up-regulated in schizophrenia brains. BMC Psychiatry 2007;7:46
21. Siegel BI, Sengupta EJ, Edelson JR, et al: Elevated viral restriction factor levels in cortical blood vessels in schizophrenia. Biol Psychiatry 2014;76:160-167
22. Huang IC, Bailey CC, Weyer JL, et al: Distinct patterns of IFITMmediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLoS Pathog 2011;7:e1001258
23. Bailey CC, Huang IC, Kam C, et al: IFITM3 limits the severity of acute influenza in mice. PLoS Pathog 2012;8:e1002909
24. Diamond MS, Farzan M: The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat Rev Immunol 2013;13:46-57
25. Meyer U, Nyffeler M, Engler A, et al: The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci 2006;26:4752-4762
26. Garay PA, Hsiao EY, Patterson PH, et al: Maternalimmuneactivation causes age- and region-specific changes in brain cytokines in offspring throughout development. Brain Behav Immun 2013;31:54-68
27. Tang B, Jia H, Kast RJ, et al: Epigenetic changes at gene promoters in response to immune activation in utero. Brain Behav Immun 2013;30:168-175
28. Volk DW, Radchenkova PV, Walker EM, et al: Cortical opioid markers in schizophrenia and across postnatal development. Cereb Cortex 2012;22:1215-1223
29. Volk DW, Chitrapu A, Edelson JR, et al: Chemokine receptors and cortical interneuron dysfunction in schizophrenia. Schizophr Res (Epub ahead of print, Nov. 11, 2014)
30. Volk DW, Austin MC, Pierri JN, et al: Decreased glutamic acid decarboxylase67 messengerRNAexpression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch Gen Psychiatry 2000;57:237-245
31. Volk DW, Eggan SM, Lewis DA: Alterations in metabotropic glutamate receptor 1a and regulator of G protein signaling 4 in the prefrontal cortex in schizophrenia. Am J Psychiatry 2010;167:1489-1498
32. Volk DW, Siegel BI, Verrico CD, et al: Endocannab inoidmetabolismin the prefrontal cortex in schizophrenia. Schizophr Res 2013;147:53-57
33. Volk DW, Edelson JR, Lewis DA: Cortical inhibitory neuron disturbances in schizophrenia: role of the ontogenetic transcription factor Lhx6. Schizophr Bull 2014;40:1053-1061
34. Hashimoto T, Bazmi HH, Mirnics K, et al: Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia. Am J Psychiatry 2008;165:479-489
35. Vandesompele J, De Preter K, Pattyn F, et al: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002;3(7):0034. 1-0034.12
36. Smith SE, Li J, Garbett K, et al: Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci 2007;27:10695-10702
37. Hsiao EY, Patterson PH: Activation of the maternal immune system induces endocrine changes in the placenta via IL-6. Brain Behav Immun 2011;25:604-615
38. Cunningham C, Campion S, Teeling J, et al: The sickness behaviour and CNS inflammatory mediator profile induced by systemic challenge of mice with synthetic double-stranded RNA (poly I:C). Brain Behav Immun 2007;21:490-502
39. Paxinos G, Franklin K: The Mouse Brain in Stereotaxic Coordinates. San Diego, Academic Press, 2001
40. Dorph-Petersen KA, Pierri JN, Perel JM, et al: The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology 2005;30:1649-1661
41. Tornatore L, Thotakura AK, Bennett J, et al: The nuclear factor kappa B signaling pathway: integrating metabolism with inflammation. Trends Cell Biol 2012;22:557-566
42. Hoesel B, Schmid JA: The complexity of NF-kB signaling in inflammation and cancer. Mol Cancer 2013;12:86
43. Takao K, Kobayashi K, Hagihara H, et al: Deficiency of schnurri-2, an MHCenhancer binding protein, induces mild chronic inflammation in the brain and confers molecular, neuronal, and behavioral phenotypes related to schizophrenia. Neuropsychopharmacology 2013;38:1409-1425
44. Radewicz K, Garey LJ, Gentleman SM, et al: Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics. J Neuropathol Exp Neurol 2000;59:137-150
45. Wierzba-Bobrowicz T, Lewandowska E, Lechowicz W, et al: Quantitative analysis of activated microglia, ramified and damage of processes in the frontal and temporal lobes of chronic schizophrenics. Folia Neuropathol 2005;43:81-89
46. Van Berckel BN, Bossong MG, Boellaard R, et al: Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study. Biol Psychiatry 2008;64:820-822
47. Doorduin J, De Vries EF, Willemsen AT, et al: Neuroinflammation in schizophrenia-related psychosis: a PET study. J Nucl Med 2009;50:1801-1807
48. Meyer U, Nyffeler M, Yee BK, et al: Adult brain and behavioral pathological markers of prenatal immune challenge during early/middleand late fetaldevelopment inmice. Brain Behav Immun 2008;22:469-486
49. Richetto J, Calabrese F, Riva MA, et al: Prenatal immune activation induces maturation-dependent alterations in the prefrontal GABAergic transcriptome. Schizophr Bull 2014;40:351-361
50. Lipina TV, Zai C, Hlousek D, et al: Maternal immune activation during gestation interacts with Disc1 point mutation to exacerbate schizophrenia-related behaviors in mice. J Neurosci 2013;33:7654-7666
51. Giovanoli S, Engler H, Engler A, et al: Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice. Science 2013;339:1095-1099
52. Hashimoto T, Volk DW, Eggan SM, et al: Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci 2003;23:6315-6326
53. Hashimoto T, Arion D, Unger T, et al: Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia. Mol Psychiatry 2008;13:147-161
54. Curley AA, Arion D, Volk DW, et al: Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features. Am J Psychiatry 2011;168:921-929
55. Volk DW, Matsubara T, Li S, et al: Deficits in transcriptional regulators of cortical parvalbumin neurons in schizophrenia. Am J Psychiatry 2012;169:1082-1091
56. Keller WR, Kum LM, Wehring HJ, et al: A review of antiinflammatory agents for symptoms of schizophrenia. J Psychopharmacol 2013;27:337-342